Shandong Qidu Pharmaceutical has been ordered by the China FDA to recall more than 20,000 bottles of injectable API combination used for treating various infections, including respiratory.
The agency said impurities “similar to furs” were found in sampled bottles.

Read the full story at www.fiercepharmamanufacturing.com